Tsui-Fen Chou, Ph.D.
Affiliations: | 2006 | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
development of approaches that will deliver anticancers drug, proteins and nucleic acids to cancer tissues and not normal tissuesGoogle:
"Tsui-Fen Chou"Mean distance: 9.13 | S | N | B | C | P |
Parents
Sign in to add mentor| Carston R. Wagner | grad student | 2006 | UMN | |
| (Histidine triad nucleotide binding proteins (Hints): Nucleoside phosphoramidases and potential regulators of aminoacyl-tRNA synthetases.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wang F, Li S, Gan T, et al. (2020) Allosteric p97 inhibitors can overcome resistance to ATP-competitive p97 inhibitors for potential anti-cancer therapy. Chemmedchem |
| LaPorte MG, Burnett JC, Colombo R, et al. (2018) Optimization of Phenyl Indole Inhibitors of the AAA+ ATPase p97. Acs Medicinal Chemistry Letters. 9: 1075-1081 |
| Li J, Zhang Y, Da Silva Sil Dos Santos B, et al. (2018) Epidithiodiketopiperazines Inhibit Protein Degradation by Targeting Proteasome Deubiquitinase Rpn11. Cell Chemical Biology |
| Srivastava AK, Govindharajulu JP, Hollingshead MG, et al. (2018) Pharmacodynamics of first-in-class p97 inhibitors that disrupt protein homeostasis in cancer. Journal of Clinical Oncology. 36: e14539-e14539 |
| Bastola P, Freudenthal B, Schaich M, et al. (2018) Abstract A40: Specific mutations in the D1-D2 linker region of VCP/p97 enhance ATPase activity and confer resistance to VCP inhibitors Clinical Cancer Research. 24 |
| Sauni CT, Wang F, Kan S, et al. (2018) Pilot enzyme replacement therapy with recombinant human glucosamine (N-acetyl)-6-sulfatase in mucopolysaccharidosis type IIID mouse model Molecular Genetics and Metabolism. 123 |
| Bastola P, Wang F, Schaich MA, et al. (2017) Specific mutations in the D1-D2 linker region of VCP/p97 enhance ATPase activity and confer resistance to VCP inhibitors. Cell Death Discovery. 3: 17065 |
| Nakasone MA, Lewis TA, Walker O, et al. (2017) Structural Basis for the Inhibitory Effects of Ubistatins in the Ubiquitin-Proteasome Pathway. Structure (London, England : 1993) |
| Shah R, Chou TF, Maize KM, et al. (2017) Inhibition by divalent metal ions of human histidine triad nucleotide binding protein1 (hHint1), a regulator of opioid analgesia and neuropathic pain. Biochemical and Biophysical Research Communications |
| Lee Y, Chou TF, Pittman SK, et al. (2017) Keap1/Cullin3 Modulates p62/SQSTM1 Activity via UBA Domain Ubiquitination. Cell Reports. 19: 188-202 |